These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 23695049)

  • 1. Dopaminergic symptoms in migraine.
    Barbanti P; Fofi L; Aurilia C; Egeo G
    Neurol Sci; 2013 May; 34 Suppl 1():S67-70. PubMed ID: 23695049
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dopamine involvement in the migraine attack.
    Fanciullacci M; Alessandri M; Del Rosso A
    Funct Neurol; 2000; 15 Suppl 3():171-81. PubMed ID: 11200788
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dopamine and migraine: biology and clinical implications.
    Akerman S; Goadsby PJ
    Cephalalgia; 2007 Nov; 27(11):1308-14. PubMed ID: 17970991
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dopaminergic symptoms in migraine: A cross-sectional study on 1148 consecutive headache center-based patients.
    Barbanti P; Aurilia C; Egeo G; Fofi L; Guadagni F; Ferroni P
    Cephalalgia; 2020 Oct; 40(11):1168-1176. PubMed ID: 32484361
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dopamine and migraine.
    Peroutka SJ
    Neurology; 1997 Sep; 49(3):650-6. PubMed ID: 9305317
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Migraine and Yawning.
    Güven B; Güven H; Çomoğlu SS
    Headache; 2018 Feb; 58(2):210-216. PubMed ID: 28960327
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dopaminergic hypersensitivity in migraine: clinical and genetic evidence.
    Del Zompo M
    Funct Neurol; 2000; 15 Suppl 3():163-70. PubMed ID: 11200787
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dopamine: what's new in migraine?
    Charbit AR; Akerman S; Goadsby PJ
    Curr Opin Neurol; 2010 Jun; 23(3):275-81. PubMed ID: 20164768
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Platelet dopamine: D2 receptor binding in patients with migraine.
    Shukla R; Khanna VK; Vinod P; Sankhwar ML; Yadav RS
    Cephalalgia; 2009 May; 29(5):532-8. PubMed ID: 19170695
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dopamine and migraine: a review of pharmacological, biochemical, neurophysiological, and therapeutic data.
    Mascia A; Afra J; Schoenen J
    Cephalalgia; 1998 May; 18(4):174-82. PubMed ID: 9642491
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Premonitory Symptoms in Episodic and Chronic Migraine From a Pediatric Headache Clinic.
    Jacobs H; Pakalnis A
    Pediatr Neurol; 2019 Aug; 97():26-29. PubMed ID: 31076200
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dopamine hypersensitivity in migraine: role of the apomorphine test.
    Cerbo R; Barbanti P; Buzzi MG; Fabbrini G; Brusa L; Roberti C; Zanette E; Lenzi GL
    Clin Neuropharmacol; 1997 Feb; 20(1):36-41. PubMed ID: 9037571
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High prevalence of Dopaminergic Premonitory Symptoms in migraine patients with Restless Legs Syndrome: a pathogenetic link?
    Cologno D; Cicarelli G; Petretta V; d'Onofrio F; Bussone G
    Neurol Sci; 2008 May; 29 Suppl 1():S166-8. PubMed ID: 18545925
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Premonitory symptoms in glyceryl trinitrate triggered migraine attacks: a case-control study.
    Onderwater GLJ; Dool J; Ferrari MD; Terwindt GM
    Pain; 2020 Sep; 161(9):2058-2067. PubMed ID: 32332251
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Current opinions on migraine pathophysiology].
    Glaubic-Łatka M; Łatka D; Bury W; Pierzchała K
    Neurol Neurochir Pol; 2004; 38(4):307-15. PubMed ID: 15383959
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The premonitory phase of migraine is due to hypothalamic dysfunction: revisiting the evidence.
    Gollion C; De Icco R; Dodick DW; Ashina H
    J Headache Pain; 2022 Dec; 23(1):158. PubMed ID: 36514014
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Video assessment of yawning induced by sublingual apomorphine in migraine.
    Del Bene E; Poggioni M; De Tommasi F
    Headache; 1994 Oct; 34(9):536-8. PubMed ID: 8002329
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Syncope during migraine attack: an effect of dopaminergic overreactivity?
    Micieli G; Cavallini A; Iannacchero R; Salerno J
    Funct Neurol; 1989; 4(3):303-4. PubMed ID: 2792868
    [No Abstract]   [Full Text] [Related]  

  • 19. Prodromes and the early phase of the migraine attack: therapeutic relevance.
    Buzzi MG; Cologno D; Formisano R; Rossi P
    Funct Neurol; 2005; 20(4):179-83. PubMed ID: 16483458
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Migraine Premonitory Phase.
    Karsan N; Bose P; Goadsby PJ
    Continuum (Minneap Minn); 2018 Aug; 24(4, Headache):996-1008. PubMed ID: 30074545
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.